(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Who was Haytham Ali Tabatabai, Hezbollah's military leader killed by Israel? - 2Health officials report 14 Legionnaires' disease cases in Florida, gym connection suspected
- 3Every year, she thanks the trooper for the arrest that led to her sobriety
- 4In these U.S. groups, deaths now exceed births. What’s happening?
- 5Geminid meteors streak under green sky | Space photo of the day for Dec. 19, 2025
- Public Parks in the USA
- Manual for Purchasing a Modest Jeep Wrangler for Seniors
- What is Fusarium graminearum, the fungus a Chinese scientist pleaded guilty to smuggling into the US?
- Washington resident is infected with a different type of bird flu
- The Incomparable Advanced cameras: Which One Will Win?
- 5 Family SUVs for 2024: Which One Accommodates Your Family's Needs\uff1f
- Osteoporosis, the silent disease, can shorten your life − here’s how to prevent fractures and keep bones healthy
- Figure out how to Detect the Best Rooftop Substitution Choices
- Top 20 Wellbeing and Wellness Applications for a Sound Way of life
